ADVOCATE. CONNECT. INNOVATE.

Category Archives: Sacramento

New Legislator Spotlight: State Senator Andreas Borgeas (R-Fresno)

On behalf of our membership and California’s statewide life sciences community – a sector which employs over 311,000 Californians – California Life Sciences Association (CLSA) welcomes State Senator Andreas Borgeas (R-Fresno). We look forward to working with Senator Borgeas and his team to advance policies that improve patient health and bring positive change for California patients and their families.

New Legislator Spotlight: Assemblywoman Buffy Wicks (D-Oakland)

On behalf of our membership and California’s statewide life sciences community – a sector which employs over 311,000 Californians, including over 82,000 in the Bay Area – California Life Sciences Association (CLSA) welcomes Assemblywoman Buffy Wicks (D-Oakland). We look forward to working with Asm. Wicks and her team to advance policies that improve patient health and bring positive change for California patients and their families.

New Legislator Spotlight: State Senator Anna Caballero (D-Salinas)

On behalf of our membership and California’s statewide life sciences community – a sector which employs over 311,000 Californians – California Life Sciences Association (CLSA) welcomes State Senator Anna Caballero (D-Salinas). We look forward to working with Senator Caballero and her team to advance policies that improve patient health and bring positive change for California patients and their families.

Governor Newsom Signs an Executive Order on State Prescription Drug Purchasing

On Monday, January 7th, asserting healthcare was a central pillar of his “California for All” agenda, newly elected Governor Gavin Newsom signed an executive order (EO) aiming to consolidate the state’s prescription drug negotiating power by fully transitioning the Medi-Cal pharmacy benefit to fee-for-service (i.e., carving-out pharmacy services from managed care) and by strengthening the state’s joint purchasing program for pharmaceuticals.

CalPERS Implements Reference-Pricing for Dozens of Drug Classes

At its Nov. 14 board meeting, CalPERS’ Pension and Health Benefits Committee directed its staff to move forward with a Request for Information (RFI) to implement a Full Reference Pricing Program, expanding from their currently proposed three drug class pilot (nasal corticosteroids, thyroid medications, and oral estrogens) to cover up to 70-80 drug classes.